New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Leveraging proteomics datasets to discover potential therapeutic targets for cancer patients

Leveraging proteomics datasets to discover potential therapeutic targets for cancer patients

A new research perspective was published inOncotarget'sVolume 14 on May 4, 2023, entitled, "Using cancer proteomics data to identify gene candidates for therapeutic targeting.&quo
World medicine November 23,2023
Leveraging proteomics datasets to discover potential therapeutic targets for cancer patients

Leveraging proteomics datasets to discover potential therapeutic targets for cancer patients

A new research perspective was published inOncotarget'sVolume 14 on May 4, 2023, entitled, "Using cancer proteomics data to identify gene candidates for therapeutic targeting.&quo
World medicine November 23,2023
UVA Cancer Center receives $250,000 to develop innovative new approach to treating leukemia

UVA Cancer Center receives $250,000 to develop innovative new approach to treating leukemia

Children's Cancer Research Fund has awarded $250,000 to an innovative new approach to treating leukemia – blood cancer – being developed at UVA Cancer Center.The grant to John H. Bushweller, PhD,
World medicine November 23,2023
UVA Cancer Center receives $250,000 to develop innovative new approach to treating leukemia

UVA Cancer Center receives $250,000 to develop innovative new approach to treating leukemia

Children's Cancer Research Fund has awarded $250,000 to an innovative new approach to treating leukemia – blood cancer – being developed at UVA Cancer Center.The grant to John H. Bushweller, PhD,
World medicine November 23,2023
Inhibiting mitochondrial regulator ATAD3A could prevent head and neck cancer development

Inhibiting mitochondrial regulator ATAD3A could prevent head and neck cancer development

A new research perspective was published inOncoscience(Volume 10) on April 4, 2023, entitled, "Mitochondrial regulator ATAD3A: a molecular determinant favoring head and neck cancer de
World medicine November 23,2023
Inhibiting mitochondrial regulator ATAD3A could prevent head and neck cancer development

Inhibiting mitochondrial regulator ATAD3A could prevent head and neck cancer development

A new research perspective was published inOncoscience(Volume 10) on April 4, 2023, entitled, "Mitochondrial regulator ATAD3A: a molecular determinant favoring head and neck cancer de
World medicine November 23,2023
IL-6 regulation in colon cancer-associated fibroblasts through vitamin A metabolism

IL-6 regulation in colon cancer-associated fibroblasts through vitamin A metabolism

A new research perspective was published inOncotarget'sVolume 14 on April 26, 2023, entitled, "Disruption of retinol-mediated IL-6 expression in colon cancer-associated fibroblast
World medicine November 23,2023
IL-6 regulation in colon cancer-associated fibroblasts through vitamin A metabolism

IL-6 regulation in colon cancer-associated fibroblasts through vitamin A metabolism

A new research perspective was published inOncotarget'sVolume 14 on April 26, 2023, entitled, "Disruption of retinol-mediated IL-6 expression in colon cancer-associated fibroblast
World medicine November 23,2023
Upregulated expression of many LY6 genes linked to poor survival in endometrial cancer patients

Upregulated expression of many LY6 genes linked to poor survival in endometrial cancer patients

A new research paper was published inOncotarget'sVolume 14 on May 4, 2023, entitled, "Human LY6 gene family: potential tumor-associatedantigensand biomarkers of progno
World medicine November 23,2023
Upregulated expression of many LY6 genes linked to poor survival in endometrial cancer patients

Upregulated expression of many LY6 genes linked to poor survival in endometrial cancer patients

A new research paper was published inOncotarget'sVolume 14 on May 4, 2023, entitled, "Human LY6 gene family: potential tumor-associatedantigensand biomarkers of progno
World medicine November 23,2023
Rapamycin and other rapalogs have potential to delay cancer

Rapamycin and other rapalogs have potential to delay cancer

A new research perspective was published inOncotarget'sVolume 14 on April 14, 2023, entitled, "Cancer prevention with rapamycin."The mTOR (Target of Rapamycin) pathway is inv
World medicine November 23,2023
Rapamycin and other rapalogs have potential to delay cancer

Rapamycin and other rapalogs have potential to delay cancer

A new research perspective was published inOncotarget'sVolume 14 on April 14, 2023, entitled, "Cancer prevention with rapamycin."The mTOR (Target of Rapamycin) pathway is inv
World medicine November 23,2023
Harnessing the forces of physics in the fight against cancer

Harnessing the forces of physics in the fight against cancer

"Physics against cancer" is a book about the origins of proton therapy at the Paul Scherrer Institute PSI.At the Centre for Proton Therapy CPT, which belongs to the Paul Scherrer Institute P
World medicine November 23,2023
Harnessing the forces of physics in the fight against cancer

Harnessing the forces of physics in the fight against cancer

"Physics against cancer" is a book about the origins of proton therapy at the Paul Scherrer Institute PSI.At the Centre for Proton Therapy CPT, which belongs to the Paul Scherrer Institute P
World medicine November 23,2023
Promising new cancer therapy appears to be extremely potent against tuberculosis

Promising new cancer therapy appears to be extremely potent against tuberculosis

Nov 16 2023Texas Biomedical Research InstituteA promising new cancer therapy also appears extremely potent against one of the world's most devastating infectious diseases: tuberculosis (TB).Scient
World medicine November 23,2023
Promising new cancer therapy appears to be extremely potent against tuberculosis

Promising new cancer therapy appears to be extremely potent against tuberculosis

Nov 16 2023Texas Biomedical Research InstituteA promising new cancer therapy also appears extremely potent against one of the world's most devastating infectious diseases: tuberculosis (TB).Scient
World medicine November 23,2023
New lipidic peptide IK14004 shows promise in treating cancer and reducing autoimmune complications

New lipidic peptide IK14004 shows promise in treating cancer and reducing autoimmune complications

ByDr. Liji Thomas, MDNov 15 2023Reviewed byLily Ramsey, LLMA recent study published in Nature’s Scientific Reports described a lipidic peptide, named IK14004, which fosters the growth of i
World medicine November 23,2023
New lipidic peptide IK14004 shows promise in treating cancer and reducing autoimmune complications

New lipidic peptide IK14004 shows promise in treating cancer and reducing autoimmune complications

ByDr. Liji Thomas, MDNov 15 2023Reviewed byLily Ramsey, LLMA recent study published in Nature’s Scientific Reports described a lipidic peptide, named IK14004, which fosters the growth of i
World medicine November 23,2023
New treatment approaches offer hope to minimize hair thinning in middle-aged women

New treatment approaches offer hope to minimize hair thinning in middle-aged women

Reviewed byEmily Henderson, B.Sc.Sep 22 2021Hair loss in middle-aged females is common, affecting up to two-thirds of women after menopause. The exact reasons remain unclear, although evidence s
World medicine November 23,2023
New treatment approaches offer hope to minimize hair thinning in middle-aged women

New treatment approaches offer hope to minimize hair thinning in middle-aged women

Reviewed byEmily Henderson, B.Sc.Sep 22 2021Hair loss in middle-aged females is common, affecting up to two-thirds of women after menopause. The exact reasons remain unclear, although evidence s
World medicine November 23,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com